These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 26436447

  • 1. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.
    Salomone F, Godos J, Zelber-Sagi S.
    Liver Int; 2016 Jan; 36(1):5-20. PubMed ID: 26436447
    [Abstract] [Full Text] [Related]

  • 2. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease.
    Abenavoli L, Larussa T, Corea A, Procopio AC, Boccuto L, Dallio M, Federico A, Luzza F.
    Nutrients; 2021 Feb 03; 13(2):. PubMed ID: 33546130
    [Abstract] [Full Text] [Related]

  • 3. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S, Kienbacher C, Halilbasic E, Rechling C, Kazemi-Shirazi L, Hofer H, Munda P, Trauner M.
    Dig Dis; 2015 Feb 03; 33(4):598-607. PubMed ID: 26159280
    [Abstract] [Full Text] [Related]

  • 4. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
    Cicero AFG, Colletti A, Bellentani S.
    Nutrients; 2018 Aug 23; 10(9):. PubMed ID: 30142943
    [Abstract] [Full Text] [Related]

  • 5. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Sugimoto K, Inui H, Fukusato T.
    World J Gastroenterol; 2015 Apr 07; 21(13):3777-85. PubMed ID: 25852263
    [Abstract] [Full Text] [Related]

  • 6. Therapies in non-alcoholic steatohepatitis (NASH).
    Oseini AM, Sanyal AJ.
    Liver Int; 2017 Jan 07; 37 Suppl 1(Suppl 1):97-103. PubMed ID: 28052626
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Taurine and tea polyphenols combination ameliorate nonalcoholic steatohepatitis in rats.
    Zhu W, Chen S, Chen R, Peng Z, Wan J, Wu B.
    BMC Complement Altern Med; 2017 Sep 08; 17(1):455. PubMed ID: 28886741
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.
    Del Ben M, Polimeni L, Baratta F, Pastori D, Angelico F.
    Br J Clin Pharmacol; 2017 Jan 08; 83(1):88-95. PubMed ID: 26852185
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD.
    Ezhilarasan D, Langeswaran K.
    Cell Biochem Funct; 2024 Sep 08; 42(7):e4112. PubMed ID: 39238138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management and diagnosis of fatty liver disease.
    Schneier AT, Citti CC, Dieterich DT.
    Expert Rev Gastroenterol Hepatol; 2015 May 08; 9(5):671-83. PubMed ID: 25716275
    [Abstract] [Full Text] [Related]

  • 15. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress.
    Ferro D, Baratta F, Pastori D, Cocomello N, Colantoni A, Angelico F, Del Ben M.
    Nutrients; 2020 Sep 10; 12(9):. PubMed ID: 32927776
    [Abstract] [Full Text] [Related]

  • 16. Phytosterols and Triterpenoids for Prevention and Treatment of Metabolic-related Liver Diseases and Hepatocellular Carcinoma.
    Sánchez-Crisóstomo I, Fernández-Martínez E, Cariño-Cortés R, Betanzos-Cabrera G, Bobadilla-Lugo RA.
    Curr Pharm Biotechnol; 2019 Sep 10; 20(3):197-214. PubMed ID: 30806308
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment.
    Argyrou C, Moris D, Vernadakis S.
    J BUON; 2017 Sep 10; 22(1):6-20. PubMed ID: 28365930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.